Aidea Pharma(688488.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Aidea Pharma
688488.SH
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products.
1.470 T
688488.SHMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
C
BiotechnologyIndustry
Industry Ranking46/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE-2.79%D
    • Profit Margin-3.93%D
    • Gross Margin67.52%A
  • Growth ScoreB
    • Revenue YoY33.77%A
    • Net Profit YoY75.44%A
    • Total Assets YoY8.64%B
    • Net Assets YoY-0.26%D
  • Cash ScoreB
    • Cash Flow Margin77.17%C
    • OCF YoY33.77%A
  • Operating ScoreD
    • Turnover0.35D
  • Debt ScoreC
    • Gearing Ratio47.08%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    China’s Jiangsu Aidea eyes Hong Kong IPO as gateway to US, European Aids markets

    SCMP·
    SZ
    002675
    -1.24%
    HK
    江苏鼎泰药物...
    0.00%
    SH
    688488
    -1.25%
    SCMP·
    SZ
    002675
    -1.24%
    HK
    江苏鼎泰药物...
    0.00%
    SH
    688488
    -1.25%

    The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had significant declines

    Wallstreetcn·
    SZ
    300016
    -3.93%
    SH
    688136
    -2.80%
    SH
    688710
    +1.71%
    Wallstreetcn·
    SZ
    300016
    -3.93%
    SH
    688136
    -2.80%
    SH
    688710
    +1.71%

    Aidea Pharma: Sodium Dolutegravir API receives approval for listing application

    Zhitong·
    SH
    688488
    -1.25%
    Zhitong·
    SH
    688488
    -1.25%

    Aidea Pharma: The full text of the 96-week study on Fubangde® SPRINT was published in BMC Medicine

    Zhitong·
    SH
    688488
    -1.25%
    Zhitong·
    SH
    688488
    -1.25%

    Aidea Pharma: Ainomit Tablets Obtains Drug Registration Certificate in Zanzibar

    Zhitong·
    SH
    688488
    -1.25%
    Zhitong·
    SH
    688488
    -1.25%
    © 2026 Longbridge｜Disclaimer